Form 4 for CRL Charles River Laboratories
Accepted 2022-12-06 00:00:00 ET · period of report 2022-06-07 · accession 0000950103-22-020817 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-12-06 | 2022-06-07 | CRL | Barbo William D | CCO, Corp. Executive VP | G - Gift | $0.00 | -391 | 3,803 | -9% | $0 |
| DM | 2022-12-06 | 2022-12-02 | CRL | Barbo William D | CCO, Corp. Executive VP | S - Sale+OE | $219.91 | -3,205 | 6,602 | -33% | -$704.8K |
| DMI | 2022-12-06 | 2022-06-07+ | CRL | Barbo William D | CCO, Corp. Executive VP | G - Gift | $0.00 | +191 | 19.0K | +1% | $0 |
| D | 2022-12-06 | 2022-12-02 | CRL | Barbo William D | CCO, Corp. Executive VP | M - OptEx | $109.34 | +3,205 | 7,008 | +84% | +$350.4K |
| D | 2022-12-06 | 2022-12-02 | CRL | Barbo William D | CCO, Corp. Executive VP | M - OptEx | $0.00 | -3,205 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-07 | G | D | 391 | $0.00 | 3,803 | D By Trust | — | — | |
| 2 | Common | Common Stock | 2022-12-02 | S | D | 873 | $219.41 | 5,729 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $218.92 to $219.83. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2022-12-02 | S | D | 700 | $221.08 | 3,803 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $220.93 to $221.32. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 4 | Common | Common Stock | 2022-12-02 | S | D | 1,226 | $220.14 | 4,503 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $219.90 to $220.34. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 5 | Common | Common Stock | 2022-06-07 | G | A | 391 | $0.00 | 19,235 | I By Trust | — | — | |
| 6 | Common | Common Stock | 2022-12-02 | S | D | 406 | $218.28 | 6,602 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $217.89 to $218.875. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 7 | Common | Common Stock | 2022-12-02 | M | A | 3,205 | $109.34 | 7,008 | D | — | — | |
| 8 | Common | Common Stock | 2022-11-15 | G | D | 200 | $0.00 | 19,035 | I | — | — | |
| 9 | Derivative | Stock Options | 2022-12-02 | M | D | 3,205 | $0.00 | 0 | D | $109.34 · 2019-02-23 to 2023-02-23 | 3,205 Common Stock |